Can prostate cancer cause lung cancer

Can prostate cancer lead to lung cancer? Hematogenous metastasis of prostate cancer is common, and cancer cells travel through the blood to bones, lungs, liver, kidneys and adrenal glands. Bone metastasis is common, followed by pelvis, lumbar spine, femur, thoracic spine, ribs, etc.; followed by lung metastasis. According to statistics, among those who died of prostate cancer, patients with lung metastasis accounted for about 30%. It is important to actively carry out treatment.

Prostate cancer is a disease that can be life-threatening once it occurs, and if not treated promptly, it can metastasize. Lung metastasis is a common site of metastasis, causing greater pain to patients, so prostate cancer lung metastasis must be treated promptly.

Also included is information about the metastatic pathways of prostate cancer

1. Direct spread: Prostate cancer spreads through the capsule to the surrounding areas and infiltrates adjacent organs. The seminal vesicles, vas deferens, bladder and pelvic organs may be affected.

2. Lymph node metastasis: Lymph node metastasis of prostate cancer occurs in the obturator and hypogastric lymph node areas, through the internal iliac, external iliac, and inguinal lymph nodes, and can extend to the inferior vena cava, mediastinum, and subclavian lymph nodes. The lower the cancer differentiation, the higher the lymph node metastasis rate.

3. Hematogenous metastasis: Hematogenous metastasis of prostate cancer is common, and cancer cells travel through the blood to bones, lungs, liver, kidneys and adrenal glands. Bone metastasis is common, in order of pelvis, lumbar spine, femur, thoracic spine, ribs, etc.; followed by lung metastasis. According to statistics, among those who died of prostate cancer, patients with lung metastasis accounted for about 30%.

How to treat lung metastasis of prostate cancer?

Prostate cancer metastasis to the lungs is very painful for patients. It not only means that the difficulty of treatment increases, but also means that the patient's life and health are further threatened. Controlling the progression of the disease, preventing the tumor from further invading other organs of the body, improving the patient's immune function, and prolonging the patient's life are the key. According to current clinical treatment experience, biological immunotherapy is the best choice.